Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2020

Open Access 01-06-2020 | Pathology | Correction

Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Authors: J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo, R. Álvarez-Alegret

Published in: Clinical and Translational Oncology | Issue 6/2020

Login to get access

Excerpt

The article Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology, written by J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo and R. Álvarez-Alegret was originally published electronically on the publisher’s internet portal on 26 September 2019 without open access. …
Metadata
Title
Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Authors
J. Remon
R. García-Campelo
E. de Álava
R. Vera
J. L. Rodríguez-Peralto
Á. Rodríguez-Lescure
B. Bellosillo
P. Garrido
F. Rojo
R. Álvarez-Alegret
Publication date
01-06-2020
Publisher
Springer International Publishing
Keyword
Pathology
Published in
Clinical and Translational Oncology / Issue 6/2020
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-020-02313-x

Other articles of this Issue 6/2020

Clinical and Translational Oncology 6/2020 Go to the issue

Research Article

Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies

Research Article

Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer

Research Article

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes

Research Article

Detection of incident breast and colorectal cancer cases from an administrative healthcare database in Catalonia, Spain

Review Article

The utilization of saliva as an early diagnostic tool for oral cancer: microRNA as a biomarker

Research Article

Detection of novel mitochondrial mutations in cytochrome C oxidase subunit 1 (COX1) in patients with familial adenomatous polyposis (FAP)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits